vaccines

Enjoy these stories?

Climate change is killing us — in more ways than one

We’ve all heard about climate change’s effect on our planet, but what about its catastrophic impact on human health?

Many elections, many consequences

With a vast number of citizens around the world voting for leaders and legislatures this year, much will depend on their trust in the electoral

Time to defend science under attack

In an age of “alternative facts” and conspiracy theories, protecting trust in science is crucial.

Poor-quality medicines are everyone’s problem

COVID-19 has shown that regulatory processes can fail anywhere, allowing poor-quality medicines through. A new detection test could help shield consumers.

(more…)

Australia’s offshore pharma conundrum

Australia is reliant on imports for the majority of its medicines – in this age of global epidemics regulatory vigilance has never been more important.

(more…)

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

(more…)

Computer modelling to aid search for HIV vaccine

The search continues at a brisk pace thanks to rapid developments in generating more potent computing power.

(more…)

Vaccines beyond COVID

For WHO Immunisation Week, we explore what could drive the next great leap forward on vaccines.

(more…)

In mRNA we trust

The mRNA vaccines developed to fight COVID were found to be safe and effective, even for pregnant women, inspiring scientists to explore their potential.

(more…)

Can we improve on a once-in-a-century TB vaccine?

It has been over 100 years since the last licensed tuberculosis vaccine. The clock is ticking to find a new one.

(more…)

Paving the way for a global malaria vaccine

Malaria impacts India more than anywhere else in southeast Asia, but relief could be on the way if the early promise of vaccines in development is fulfilled.

(more…)

Interview transcript: Dear Pandemic, these ‘nerdy girls’ are coming for you

In this 8-minute interview Dear Pandemic founder and public health scientist Lindsey Leininger discusses how to speak with the vaccine hesitant.

(more…)

Managing COVID in 2022: first do no harm

After two years of living through a pandemic, the consensus is we must learn to live with coronavirus. It’s time to evaluate our mitigation strategies.

(more…)

Omicron is a product of vaccine apartheid

The unintended consequence of vaccine apartheid has left billions of people in poor countries unvaccinated – creating opportunities for COVID-19 to mutate.

(more…)

About Us

More

Stay up to date

Enjoy these stories?

Climate change is killing us — in more ways than one

Many elections, many consequences

Time to defend science under attack

Poor-quality medicines are everyone’s problem

Australia’s offshore pharma conundrum

Patent waiver is no silver bullet, even during COVID-19

Computer modelling to aid search for HIV vaccine

Vaccines beyond COVID

In mRNA we trust

Can we improve on a once-in-a-century TB vaccine?

Paving the way for a global malaria vaccine

Interview transcript: Dear Pandemic, these ‘nerdy girls’ are coming for you

Managing COVID in 2022: first do no harm

Omicron is a product of vaccine apartheid

Enjoy these stories?

About

Our Policies

For journalists & newsrooms

For researchers

For non-media organisations